5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.25▲ | 1.25▲ | 1.25▲ | 1.24▲ | 1.26▼ |
MA10 | 1.25▲ | 1.25▲ | 1.25▲ | 1.26▼ | 1.30▼ |
MA20 | 1.26▲ | 1.26▲ | 1.26▲ | 1.27▼ | 1.27▼ |
MA50 | 1.27▼ | 1.26▼ | 1.26▼ | 1.30▼ | 1.46▼ |
MA100 | 1.28▼ | 1.33▼ | 1.35▼ | 1.29▼ | 6.31▼ |
MA200 | 1.36▼ | 1.35▼ | 1.30▼ | 1.34▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▲ | 0.000▲ | 0.001▲ | -0.005▼ | 0.067▲ |
RSI | 50.335▲ | 50.120▲ | 49.832▼ | 44.494▼ | 41.556▼ |
STOCH | 73.333 | 55.556 | 55.556 | 28.003 | 43.959 |
WILL %R | -20.000▲ | -20.000▲ | -20.000▲ | -58.678 | -61.988 |
CCI | 50.877 | 43.411 | 43.411 | -88.742 | -3.117 |
CDL | $ANTX Doji Candlestick Pattern Detected | Set Alert |
Wednesday, April 30, 2025 03:59 AM
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 1.23 | 1.2696 | 1.2105 | 1.24 | 66,659 |
30/04/25 | 1.22 | 1.28 | 1.22 | 1.24 | 17,316 |
29/04/25 | 1.22 | 1.22 | 1.22 | 1.22 | 21,877 |
28/04/25 | 1.25 | 1.29 | 1.24 | 1.24 | 43,830 |
25/04/25 | 1.29 | 1.29 | 1.22 | 1.25 | 74,182 |
24/04/25 | 1.26 | 1.31 | 1.24 | 1.29 | 30,278 |
23/04/25 | 1.31 | 1.3252 | 1.27 | 1.27 | 23,813 |
22/04/25 | 1.26 | 1.315 | 1.26 | 1.315 | 17,658 |
21/04/25 | 1.27 | 1.30 | 1.24 | 1.25 | 17,262 |
17/04/25 | 1.27 | 1.29 | 1.24 | 1.26 | 65,575 |
|
|
||||
|
|
||||
|
|